SURFACE LOGIX INC

surface logix inc. uses its expertise in biophysical chemistry to create new small molecule drugs that are optimized to meet the challenges of human physiology. the company is advancing multiple internal programs focused primarily on cardiovascular disease, oncology and metabolic disorders and works with strategic partners to create differentiated new chemical entities.

Products & Services

Year Established 1999
Annual Sales US$2.5 Million - US$5 Million
Business Type Service

Web Site Results

Surface Logix appoints...
...CEO of Surface Logix. "As a pharmaceutical executive, Marc has led the ...specialties of Infectious Diseases and Oncology at the National Institutes of ...internal programs focused primarily on cardiovascular disease,
Surface Logix to Present...
...SURFACE LOGIX TO PRESENT CLINICAL CANDIDATE FOR DYSLIPIDEMIA AND OBESITY AT ...have accomplished something many large pharmaceutical companies have failed to demonstrate. ...SLx-4090 is expected to lead to reduced fat
Surface Logix Announces...
...brings over 10 years of Pharmaceutical experience to Surface Logix. She ...teams, has extensive experience developing leads into drug candidates and is well versed in ...internal programs focused primarily on cardiovascular,
March 9, 2009
...our clinical pipeline of drug candidates and our discovery capabilities, said ...advance our novel metabolic and cardiovascular programs: Complete Phase 2b studies ...studies for SLx-2119, the lead compound in our
Surface Logix appoints...
...internal programs focused primarily on cardiovascular disease, oncology and metabolic disorders and works
View Larger Map